DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR033 MCLF100SZ 6H B23 oligomycin-a 2.22uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF100SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR033 MCLF100SZ 6H B23 oligomycin-a 2.22uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:311 KB

Size In Bytes:131 KB

Sha256:37f4d305a8ab5d1126372418375bae090a5e51e8dcee8c0391e6a36eb0b3fddf

Persistent Id:drs://drs.lincs-dcic.org/40166aa5f2d1550abc516dc37d64ab4a

Mime Type:application/gzip

Md5:40166aa5f2d1550abc516dc37d64ab4a

Filename:L1000_LINCS_DCIC_FIBR033_MCLF100SZ_6H_B23_oligomycin-a_2.22uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/40166aa5f2d1550abc516dc37d64ab4a

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR033 MCLF100SZ 6H B23 oligomycin-a 2.22uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR033 MCLF100SZ 6H B23 oligomycin-a 2.22uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.